Basic Information
LncRNA/CircRNA Name | LINC01138 |
Synonyms | LINC01138, LINC00875 |
Region | GRCh38_1:148290889-148519604 |
Ensemble | ENSG00000274020 |
Refseq | NR_027468 |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | Drug | |||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | prostate cancer |
ICD-0-3 | C61.9 |
Methods | Microarray, qPCR etc. |
Sample | prostate cancer tissues, cell lines (LNCaP) |
Expression Pattern | down-regulated |
Function Description | Five lncRNAs, RP1-4514.2, SUZ12P1, SNHG5, LINC01138, and SNHG1, were down-regulated under DHT treatment. Five lncRNAs, KLKP1, LINC00969, LINC-PINT, TUG1 and MIR17HG, were up-regulated under DHT treatment. Notably, RP1-4514.2 and LINC01138 were induced and KLKP1 was reduced over 2 fold after AR silenced, suggesting the involvement of AR in androgen-mediated regulation of these lncRNAs expressions. |
Pubmed ID | 27556357 |
Year | 2016 |
Title | Identification of androgen-responsive lncRNAs as diagnostic and prognostic markers for prostate cancer. |
External Links
Links for LINC01138 | GenBank HGNC NONCODE |
Links for prostate cancer | OMIM COSMIC |